JM2 Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
905
+28
+3% +$28.6K 0.74% 33
2026
Q1
$807K Sell
877
-10
-1% -$10.1K 0.67% 41
2025
Q4
$953K Buy
+887
New +$848K 0.77% 35

Other funds holding LLY

JM2 Capital's LLY Position: Q2 2026 in Review

JM2 Capital increased its Eli Lilly (LLY) stake by 3.2% in Q2 2026, buying an estimated $28.6K and bringing the position to 905 shares worth $1.09M. The position accounts for 0.74% of the portfolio, ranked #33.

JM2 Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • JM2 Capital held 905 shares of Eli Lilly worth $1.09M as of Q2 2026.
  • JM2 Capital bought 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.74% of JM2 Capital's portfolio in Q2 2026, its #33 holding.
  • JM2 Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on JM2 Capital's 13F filing for Q2 2026, filed 22 Jul 2026.